xGen HIV Amplicon Panel provides a single-tube, 2.5-hour workflow designed to enable detection down to 1,000 viral genome copies.

Studies will focus on priority populations underrepresented in HIV clinical research.

A new study involving University of Bristol researchers shows a virus-like particle (HLP) can effectively ‘shock and kill’ latent HIV reservoir in those living with chronic HIV...

NIH-funded research networks provide evidence on cabotegravir and rilpivirine in additional populations.

NIH-funded trial shows promising outcomes with treatment started promptly after birth.

NIH-funded findings inform interdisciplinary care approach across the lifespan.

Multi-country findings provide evidence on HIV prevention for a priority population.

NIH trial reveals need for more accurate screening in Black people and cisgender women.

Detailed interim results will soon be shared through scientific channels.

Human immunodeficiency virus (HIV) is an RNA (ribonucleic acid) virus that infects human immune cells, in particular CD4 T lymphocytes and is acquired through mucosal or intravenous...